Managing the microbiological safety of blood for transfusion: A US perspective

Future Microbiology

Volumn 4, Issue 7, 2009, Pages 807-818

  Dodd, Roger ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

Blood donation; Blood transfusion; Infectious disease; Safety

Indexed keywords

THROMBOCYTE CONCENTRATE;

ARTICLE; BABESIOSIS; BACTERIUM CONTAMINATION; BLOOD DONOR; BLOOD TRANSFUSION; CHIKUNGUNYA ALPHAVIRUS; CYTOMEGALOVIRUS INFECTION; DENGUE; DEVELOPING COUNTRY; DISEASE TRANSMISSION; DONOR SELECTION; HEPATITIS A; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; MALARIA; MICROBIAL CONTAMINATION; NONHUMAN; PARVOVIRUS INFECTION; PATIENT SAFETY; POSTTRANSFUSION HEPATITIS; PRIORITY JOURNAL; RISK REDUCTION; SCREENING TEST; SYPHILIS; TRYPANOSOMA CRUZI; UNITED STATES; VARIANT CREUTZFELDT JAKOB DISEASE; WEST NILE FLAVIVIRUS;

BLOOD; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; CROSS INFECTION; DISEASE TRANSMISSION, INFECTIOUS; HUMANS; INFECTION CONTROL; RISK MANAGEMENT; UNITED STATES;

TRYPANOSOMA CRUZI; WEST NILE VIRUS;

EID: 70349224592     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.09.63     Document Type: Article

References (42)

1. Dodd RY: Current estimates of transfusion safety worldwide. Dev. Biol. (Basel) 120, 3-10 (2005).
2. Kleinman S, Busch MP, Korelitz JJ, Schreiber GB: The incidence window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection. Transfus. Med. Rev. 11(3), 155-172 (1997).
3. Stramer SL, Glynn SA, Kleinman SH et al.: Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N. Engl. J. Med. 351(8), 760-768 (2004).
4. Stramer SL: Viral diagnostics in the arena of blood donor screening. Vox Sang. 87(Suppl. 2), 180-183 (2004).
5. Orton S: Syphilis and blood donors: what we know, what we do not know, and what we need to know. Transfus. Med. Rev. 15(4), 282-291 (2001).
6. Orton SL, Liu H, Dodd RY, Williams AE, Arenet EG: Prevalence of circulating Treponema pallidum DNA and RNA in blood donors with confirmed-positive syphilis tests. Transfusion 42(1), 94-99 (2002).
7. Stramer SL: Pooled hepatitis B virus DNA testing by nucleic acid amplification: implementation or not. Transfusion 45 (8), 1242-1246 (2005).
8. Satake M, Taira R, Yugi H et al.: Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Transfusion 47(7), 1197-1205 (2007).
9. Biswas R, Tabor E, Hsia CC et al.: Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 43(6), 788-798 (2003).
10. Zou S, Stramer SL, Notari EP et al.: Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Tranfusion (2009) (Epub ahead of print).
11. Barre-Sinoussi F, Chermann J-C, Rey F et al.: Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220, 868-871 (1983).
12. Gallo RC, Salahuddin SZ, Popovic M et al.: Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224, 500-503 (1984).
13. Sarngadharan MG, Popovic M, Bruch L, Schupbach J, Gallo RC: Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science 224, 506-508 (1984).
14. Murphy EL, Wang B, Sacher RA et al.: Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-III infection. Emerg. Infect. Dis. 10(1), 109-116 (2004).
15. White NJ: Plasmodium knowlesi: the fifth human malaria parasite. Clin. Infect. Dis. 46(2), 172-173 (2008).
16. Mungai M, Tegtmeier G, Chamberland M, Parise M: Transfusion-transmitted malaria in the United States from 1963 through 1999. N. Engl. J. Med. 344(26), 1973-1978 (2001).
17. Seed CR, Kitchen A, Davis TM: The current status and potential role of laboratory testing to prevent transfusion transmitted malaria. Transfus. Med. Rev. 19(3) 229-240 (2005).
18. Drew WL, Tegtmeier G, Alter HJ, Laycock ME, Miner RC, Busch MP: Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipients. Tranfusion 43(3), 309-313 (2003).
19. Blajchman MA, Goldman M, Freedman JJ, Sher GD: Proceedings of a consensus conference: prevention of post-transfusion CMV in the era of universal leukoreduction. Transfus. Med. Rev. 15(1), 1-20 (2001).
20. Biggerstaff BJ, Petersen LR: Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, - New York City. Transfusion 42 (8), 1019-1026 (2002).
21. Pealer LN, Marfin AA, Petersen LR et al.: Transmission of West Nile virus through blood transfusion in the United States in 2002. N. Engl. J. Med. 349(13), 1236-1245 (2003).
22. Stramer SL, Fang CT, Foster GA, Wagner AG, Brodsky JP, Dodd RY: West Nile virus among blood donors in the United States, 2003 and 2004. N. Engl. J. Med. 353(5), 451-459 (2005).
23. Stramer SL, Foster GA, Herron RM et al.: US blood donor screening for Trypanosoma cruzi: clinical studies and early assessment of prevalence. Transfusion 47(Suppl. 3), 1A (2008) (Abstract).
24. Eder AF, Kennedy JM, Dy B et al.: Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Creas experience (2004-2006). Transfusion 47(7), 1134-1142 (2007).
25. Eder AF, Kennedy JM, Dy BA et al.: Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safety. Transfusion (2009) (Epub ahead of print).
26. Kuehnert MJ, Roth VR, Haley NR et al.: Transfusion-transmitted bacterial infection in the United States, 1998 2000. Tranfusion 41(12), 1493-1499 (2001).
27. Alter HJ, Stramer SL, Dodd RY: Emerging infectious diseases that threaten the blood supply. Semin. Hematol. 44(1), 32-41 (2007).
28. Dodd RY, Leiby DA: Emerging infectious threats to the blood supply. Annu. Rev. Med. 55, 191-207 (2004).
29. Dodd RY: Current risk for transfusion transmitted infections. Curr. Opin. Hematol. 14(6), 671-676 (2007).
30. Hewitt PE, Llewelyn CA, Mackenzie J, Will RG: Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang. 91(3), 221-230 (2006).
31. Gregori L, Gurgel PV, Lathrop JT et al.: Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins. Lancet 368 (9554), 2226-2230 (2006).
32. Sowemimo-Coker SO, Pesci S, Andrade F et al.: Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates. Vox Sang. 90 (4), 265-275 (2006).
33. Teo D, Ng LC, Lam S: Is dengue a threat to the blood supply? Transfus. Med. 19(2), 66-77 (2009).
34. Linnen JM, Vinelli E, Sabino EC et al.: Dengue viremia in blood donors from Honduras, Brazil, and Australia. Transfusion 48(7), 1355-1362 (2008).
35. Mohammed H, Linnen JM, Munoz-Jordan JL et al.: Dengue virus in blood donations, Puerto Rico, 2005. Tranfusion 48(7), 1348-1354 (2008).
36. Charrel RN, de Lamballerie X, Raoult D: Chikungunya outbreaks - the globalization of vectorborne diseases. N. Engl. J. Med. 356(8), 70-771 (2007).
37. Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S: A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog. 3(12), e201 (2007).
38. Rezza G, Nicoletti L, Angelini R et al.: Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 370 (9602), 1840-1846 (2007).
39. Leiby DA: Babesiosis and blood transfusion: flying under the radar. Vox Sang. 90 (3), 157-165 (2006).
40. Webert KE, Cserti CM, Hannon J et al.: Proceedings of a consensus conference: pathogen inactivation-making decisions about new technologies. Transfus. Med. Rev. 22(1), 1-34 (2008).
41. Gubernot DM, Lucey CT, Lee KC, Conley GB, Holness LG, Wise RP: Babesia infection through blood transfusions: reports received by the US Food and Drug Administration, 1997-2007. Clin. Infect. Dis. 48(1), 25-30 (2009).
42. Busch MP: Transfusion-transmitted viral infections: building bridges to transfusion medicine to reduce risks and understand epidemiology and pathogenesis. Transfusion 46, 1624-1640 (2006).